METTL3 and breast carcinoma: Intriguingly, METTL3 could upregulate HBXIP in an m6A-dependent manner, which forms a positive feedback loop of HBXIP/let-7 g/METTL3/HBXIP, and thereby accelerates breast cancer cell proliferation [92].